We are live on ! Find out more
INVA icon

Innoviva

280 hedge funds and large institutions have $1.5B invested in Innoviva in 2025 Q4 according to their latest regulatory filings, with 47 funds opening new positions, 102 increasing their positions, 91 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,483% more call options, than puts

Call options by funds: $1.1M | Put options by funds: $24K

68% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 28

12% more repeat investments, than reductions

Existing positions increased: 102 | Existing positions reduced: 91

9% more capital invested

Capital invested by funds: $1.38B → $1.5B (+$122M)

6% more funds holding

Funds holding: 264280 (+16)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

19.52% less ownership

Funds ownership: 120.21%100.69% (-20%)

Holders
280
Holders Change
+16
Holders Change %
+6.06%
% of All Funds
3.39%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
47
Increased
102
Reduced
91
Closed
28
Calls
$1.1M
Puts
$24K
Net Calls
+$1.08M
Net Calls Change
+$3.69M

INVA Hedge Fund Activity: Q4 2025 in Review

280 of the 8,267 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q4 2025, worth a combined $1.5B — up 8.8% from $1.38B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new INVA positions and 28 closed out — a net gain of 19 holders — while 102 added to existing stakes and 91 trimmed.

The largest buyer was BlackRock, adding an estimated $24.2M. The largest seller was Royal Bank of Canada, cutting an estimated $23.2M.

  • 280 institutional investors held Innoviva (INVA) as of Q4 2025, up from 264 in Q3 2025.
  • Funds reported $1.5B of Innoviva stock for Q4 2025, up 8.8% quarter-over-quarter.
  • 47 funds opened new Innoviva positions in Q4 2025 and 28 closed out, a net change of +19 holders.
  • The largest Innoviva buyer in Q4 2025 was BlackRock, an estimated $24.2M added.
  • The largest Innoviva seller in Q4 2025 was Royal Bank of Canada, an estimated $23.2M sold.

Based on aggregated 13F filings for Q4 2025.